Invention Grant
US07767225B2 Capsule formulation of pirfenidone and pharmaceutically acceptable excipients
有权
吡非尼酮和药学上可接受的赋形剂的胶囊制剂
- Patent Title: Capsule formulation of pirfenidone and pharmaceutically acceptable excipients
- Patent Title (中): 吡非尼酮和药学上可接受的赋形剂的胶囊制剂
-
Application No.: US12426182Application Date: 2009-04-17
-
Publication No.: US07767225B2Publication Date: 2010-08-03
- Inventor: Ramachandran Radhakrishnan , Ronald Vladyka , Kenneth Sultzbaugh
- Applicant: Ramachandran Radhakrishnan , Ronald Vladyka , Kenneth Sultzbaugh
- Applicant Address: US CA Brisbane
- Assignee: Intermune, Inc.
- Current Assignee: Intermune, Inc.
- Current Assignee Address: US CA Brisbane
- Agency: Marshall, Gerstein & Borun LLP
- Agent John A. Bendrick
- Main IPC: A61K9/48
- IPC: A61K9/48 ; A61K9/14
Abstract:
A capsule formulation of pirfenidone is provided that includes pharmaceutically acceptable excipients. In one embodiment, this capsule formulation is capable of sustaining desirable pharmacokinetic responses in a patient. Further provided are methods of treating fibrotic conditions and other cytokine-mediated disorders by administering pirfenidone capsules of such formulation to a patient in need.
Public/Granted literature
- US20090191265A1 Capsule Formulation of Pirfenidone and Pharmaceutically Acceptable Excipients Public/Granted day:2009-07-30
Information query
